Snowball logo
logo
CYTK_logo

Cytokinetics, Incorporated

$65.91+$2.94  (4.67%)

Frequently asked questions

What sector does Cytokinetics, Incorporated (CYTK) operate in?

Cytokinetics, Incorporated belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Cytokinetics, Incorporated (CYTK) current stock price?

As of the latest data, Cytokinetics, Incorporated stock price is $65.91, with a previous close of $62.97. Cytokinetics, Incorporated gained $2.94 in the last trading session, representing a 4.67% increase.

What is Cytokinetics, Incorporated (CYTK) current market capitalization?

Cytokinetics, Incorporated market cap is approximately 8.06 billion.

What is Cytokinetics, Incorporated (CYTK) Earnings Per Share (EPS)?

The trailing EPS is -$6.54, and the forward EPS is -$4.66.

What is Cytokinetics, Incorporated (CYTK) EBITDA?

Cytokinetics, Incorporated EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -180.35 million.

Does Cytokinetics, Incorporated (CYTK) pay dividends?

No. Cytokinetics, Incorporated does not pay a dividend.

How did Cytokinetics, Incorporated (CYTK) perform in its most recent earnings report?

In the last report (December 31, 2025), Cytokinetics, Incorporated posted an EPS surprise of 3.85% and a revenue surprise of -78.09%.

When is Cytokinetics, Incorporated (CYTK) next earnings report?

Cytokinetics, Incorporated is expected to release its next earnings report on March 31, 2026.

What is Cytokinetics, Incorporated (CYTK) beta (volatility) score?

Cytokinetics, Incorporated has a beta of 0.508, indicating lower volatility than the overall market.